Pro-Assurance 8-K 2009
Item 7.01 REGULATION FD DISCLOSURE
On May 20, 2009 we issued a news release (included as Exhibit 99.1) announcing the re-election of John J. McMahon, Jr., William H. Woodhams, M.D., and Wilfred W. Yeargan, M.D. to the Board of Directors at the 2009 Annual Meeting of Shareholders. Our shareholders also elected Jerry D. Brant, D.P.M., the President and Chief Operating Officer of the Podiatry Insurance Company of America to the Board. Each will serve a three-year term ending at the Annual Meeting of Shareholders in 2012 and until their successors are elected and qualified. The shareholder vote also ratified the selection of Ernst & Young, LLP as our independent auditing firm for the fiscal year-ending December 31, 2009.
Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS
We are furnishing Exhibit 99.1 to this Current Report on Form 8-K in accordance with Item 7.01, Regulation FD Disclosures. This exhibit shall not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.
Pursuant to the requirements of the Securities Exchange act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 20, 2009
by: /s/ Frank B. O’Neil
Frank B. O’Neil